Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 325
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04035538 | A Clinical Study to Compare the Safety and Pharmacokinetics of CKD-320 and D012 | ||
| NCT02288338 | CKD-391 DDI : Atorvastatin and Ezetimibe in Healthy Volunteers | ||
| NCT04156685 | Pharmacokinetics, Safety and Tolerability of CKD-387 10/500mg BE Phase1 | ||
| NCT03437785 | Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 Tablet | ||
| NCT03067194 | The Study to Evaluate Efficacy and Safety of Celecoxib Capsule in Hand Osteoarthritis Patients | ||
| NCT03849495 | Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-370 and D745 in Healthy Adults | ||
| NCT03051841 | CKD-581 + Bortezomib + Dexamethasone in Patients With Previously Treated Multiple Myeloma | ||
| NCT07304726 | Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.25/12.5/1000mg in Healthy Volunteers | ||
| NCT06954766 | Initial Pilot Study to Evaluate the Safety and Temporary Symptom Improvement Efficacy of CKD-981 | ||
| NCT03671941 | Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-357 and D578 in Healthy Volunteers | ||
| NCT05931224 | Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy | ||
| NCT05834595 | A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828 | ||
| NCT01895894 | Mycophenolate Mofetil in Pediatric Steroid Dependent Nephrotic Syndrome | ||
| NCT03382756 | A Clinical Trial to Assess the Effects of Food on the Bioavailability of CKD-337 | ||
| NCT02064621 | CKD-330 Drug-Drug Interaction Study (Candesartan) | ||
| NCT02159976 | Compare Sequential and Quadruple Therapy for the Eradication of Helicobacter Pylori in Korea | ||
| NCT01030679 | Evaluate the Glycemic Control of CKD-501 in Type 2 Diabetes Mellitus | ||
| NCT03849261 | Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 in Healthy Adults | ||
| NCT07304687 | Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.5/25/1000mg in Healthy Volunteers | ||
| NCT02250833 | CKD-828 (80/5mg) Pharmacokinetic Study | ||
| NCT04869800 | Evaluate the Drug-drugs Interaction Between Lobeglitazone 0.5mg and Empagliflozin 25mg | ||
| NCT01991145 | Allogeneic UCB Therapy With EPO in Children With CP | ||
| NCT03762369 | A Clinical Study to Evaluate the Efficacy and Safety of CKD-351 | ||
| NCT06204107 | A Clinical Trial to Evaluate the Food Effect on Pharmacokinetic Profiles and Safety of CKD-379 | ||
| NCT04906785 | Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions | ||
| NCT06399068 | Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fed Conditions | ||
| NCT03382795 | Retreatment With Epidermal Growth Factor Receptor(EGFR) Tyrosine Kinase Inhibitor in EGFR Mutation Positive Patients | ||
| NCT03726853 | The Clinical Trial to Evaluate the Efficacy and Safety of CKD-497 | ||
| NCT03738449 | The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-387 Under Fed Condition | ||
| NCT04673864 | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386 | ||
| NCT02247518 | CKD-397 Drug-drug Interaction Study (A) | ||
| NCT04706286 | Clinical Trial to Investigate the Pharmacokinetics and Safety of CKD-393 | ||
| NCT02206165 | A Dose Selection Trial of CKD-330 in Patients With Essential Hypertension | ||
| NCT04867200 | A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344 in Healthy Volunteers | ||
| NCT02801526 | Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - A | ||
| NCT01356017 | CKD-828 Drug Interaction Study (Telmisartan) | ||
| NCT04952506 | Clinical Study to Compare the Pharmacokinetics and Safety of D113 With CKD-349 in Healthy Volunteers | ||
| NCT01028859 | Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers | ||
| NCT03431623 | CKD-11101 Phase 3 SC Study | ||
| NCT01819870 | Study to Compare the Pharmacokinetic Characteristics and Safety of Dilatrend SR Capsule 32mg and Dilatrend Tablet 25mg | ||
| NCT05719155 | Pharmacokinetics and Safety/Tolerability of CKD-379 | ||
| NCT04810676 | A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-383. | ||
| NCT03609606 | A Study to Investigate Drug Interaction Between D326, D337, and D013 in Healthy Male Subjects | ||
| NCT01634295 | Efficacy and Safety of CKD-828 to Stage 2 Hypertension | ||
| NCT07304700 | Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.5/10/1000mg in Healthy Volunteers | ||
| NCT02047175 | CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin) | ||
| NCT03858725 | Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-374 5 mg in Healthy Volunteers | ||
| NCT03558425 | A Study to Compare PK, PD and Safety of CKD-381 and D026 in Healthy Subjects | ||
| NCT04345796 | Pharmacological Reduction of Right Ventricular Enlargement | ||
| NCT05566028 | The Efficacy and Safety of D745 Added to D150 Plus D759 Therapy in Patients with Type 2 Diabetes |
